Equity Overview
Price & Market Data
Price: $0.69
Daily Change: -$0.0089 / 1.29%
Daily Range: $0.69 - $0.72
Market Cap: $61,904,868
Daily Volume: 69,623
Performance Metrics
1 Week: -5.47%
1 Month: 9.19%
3 Months: -10.72%
6 Months: -27.86%
1 Year: -68.91%
YTD: -34.28%
Company Details
Employees: 12
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.